Increased expression and activity of 11β-HSD-1 in diabetic islets and prevention with troglitazone
- 1 January 2004
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 313 (3) , 594-599
- https://doi.org/10.1016/j.bbrc.2003.11.160
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Cortisol Metabolism and Visceral Obesity: Role of 11β‐Hydroxysteroid Dehydrogenase Type I Enzyme and Reduced Co‐factor NADPHEndocrine Research, 2003
- A Transgenic Model of Visceral Obesity and the Metabolic SyndromeScience, 2001
- Mechanisms of dysregulation of 11 beta-hydroxysteroid dehydrogenase type 1 in obese Zucker ratsJournal of Endocrinology, 2000
- Type 1 11β-Hydroxysteroid Dehydrogenase Mediates Glucocorticoid Activation and Insulin Release in Pancreatic IsletsJournal of Biological Chemistry, 2000
- The Role of 11 β-Hydroxysteroid Dehydrogenase in Central Obesity and OsteoporosisEndocrine Research, 2000
- Lipoapoptosis in Beta-cells of Obese Prediabeticfa/fa RatsJournal of Biological Chemistry, 1998
- Substitution at Codon 269 (Glutamine → Proline) of the Leptin Receptor (OB-R) cDNA Is the Only Mutation Found in the Zucker Fatty (fa/fa) RatBiochemical and Biophysical Research Communications, 1996
- Leptin receptor missense mutation in the fatty Zucker ratNature Genetics, 1996
- The relationship of blood pressure with glucose, insulin, heart rate, free fatty acids and plasma cortisol levels according to degree of obesity in middle-aged menJournal Of Hypertension, 1996
- Roles of insulin resistance and beta-cell dysfunction in dexamethasone-induced diabetes.Journal of Clinical Investigation, 1992